Grayling

Adaptive Designs: Benefits and Cautions for Neurosurgery Trials

When is a two-stage single-arm trial efficient? An evaluation of the impact of outcome delay

Optimised point estimators for multi-stage single-arm phase II oncology trials

Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials

Response adaptive intervention allocation in stepped-wedge cluster randomized trials

Two-Stage Single-Arm Trials Are Rarely Analyzed Effectively or Reported Adequately

Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential

*BMC Rheumatology* 2021; 5:21

Accounting for variation in the required sample size in the design of group-sequential trials

*Contemporary Clinical Trials* 2021; 107:106459

A review of Bayesian perspectives on sample size derivation for confirmatory trials

*The American Statistician* 2021; DOI:10.1080/00031305.2021.1901782

Treatment allocation strategies for umbrella trials in the presence of multiple biomarkers: A comparison of methods

*Pharmaceutical Statistics* 2021; doi:10.1002/pst.2119